Proton pump inhibitors and antibiotics impact on toxicities and clinical outcomes in cancer patients treated with immunotherapy.

被引:4
|
作者
Araujo, Haniel Alves
Venchiarutti Moniz, Camila Motta
Melro Braghiroli, Oddone Freitas
Mak, Milena Perez
Uratani, Lucas Fernando
Tiecher, Ricardo Dahmer
Moraes, Priscila Muniz
Barbosa, Ingrid
De Camargo, Veridiana Pires
Freitas Melro Braghiroli, Maria Ignez
Castro, Gilberto
Hoff, Paulo Marcelo
Diz, Maria Del Pilar
机构
[1] Inst Canc Estado Sao Paulo ICESP, Sao Paulo, Brazil
[2] Inst DOr Pesquisa & Ensino, Sao Paulo, Brazil
[3] Univ Sao Paulo, Inst Canc Estado Sao Paulo, Sao Paulo, Brazil
[4] Univ Sao Paulo, Sao Paulo, Brazil
关键词
D O I
10.1200/JCO.2021.39.15_suppl.2652
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2652
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma
    Okuyama, Yoshiharu
    Hatakeyama, Shingo
    Numakura, Kazuyuki
    Narita, Takuma
    Tanaka, Toshikazu
    Miura, Yuki
    Sasaki, Daichi
    Noro, Daisuke
    Tokui, Noriko
    Okamoto, Teppei
    Yamamoto, Hayato
    Narita, Shintaro
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Habuchi, Tomonori
    Ohyama, Chikara
    BJUI COMPASS, 2022, 3 (02): : 154 - 161
  • [22] Association of Antibiotics and Other Drugs with Clinical Outcomes in Metastatic Melanoma Patients Treated with Immunotherapy
    Angrish, Manish D.
    Agha, Arun
    Pezo, Rossanna C.
    JOURNAL OF SKIN CANCER, 2021, 2021
  • [23] Expectations of cure among patients with advanced genitourinary cancer treated with immunotherapy.
    Bergerot, Cristiane Decat
    Bergerot, Paulo Gustavo
    Philip, Errol James
    Hsu, Joann
    Dizman, Nazli
    Vaishampayan, Ulka N.
    Dorff, Tanya B.
    Pal, Sumanta K.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [24] Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study
    Emre Yekedüz
    Mehmet Fatih Özbay
    Dilek Çağlayan
    Atila Yıldırım
    Cihan Erol
    Hasan Çağrı Yıldırım
    Sezai Tunç
    Neslihan Özyurt
    Feyyaz Özdemir
    Mehmet Ali Nahit Şendur
    Abdurrahman Işıkdoğan
    Saadettin Kılıçkap
    Yüksel Ürün
    Şuayib Yalçın
    Mehmet Artaç
    Hasan Şenol Coşkun
    Güngör Utkan
    European Journal of Clinical Pharmacology, 2022, 78 : 1973 - 1979
  • [25] Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study
    Yekeduz, Emre
    Ozbay, Mehmet Fatih
    Caglayan, Dilek
    Yildirim, Atila
    Erol, Cihan
    Yildirim, Hasan Cagri
    Tunc, Sezai
    Ozyurt, Neslihan
    Ozdemir, Feyyaz
    Sendur, Mehmet Ali Nahit
    Isikdogan, Abdurrahman
    Kilickap, Saadettin
    Urun, Yuksel
    Yalcin, Suayib
    Artac, Mehmet
    Coskun, Hasan Senol
    Utkan, Gungor
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (12) : 1973 - 1979
  • [26] Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: A multicenter study
    Yekeduz, Emre
    Ozbay, Mehmet Fatih
    Caglayan, Dilek
    Yildirim, Atila
    Erol, Cihan
    Yildirim, Hasan Cagri
    Tunc, Sezai
    Ozyurt, Neslihan
    Ozdemir, Feyyaz
    Sendur, Mehmet Ali Nahit
    Isikdogan, Abdurrahman
    Kilickap, Saadettin
    Urun, Yuksel
    Yalcin, Suayib
    Artac, Mehmet
    Coskun, Hasan Senol
    Utkan, Gungor
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [27] The effect of proton pump inhibitor uses on outcomes for cancer patients treated with immune checkpoint inhibitors: a meta-analysis
    Li, Chao
    Xia, Zhengzheng
    Li, Anna
    Meng, Jun
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (24)
  • [28] Impact of age and frailty markers on overall survival among hospitalized patients with lung cancer treated with immunotherapy.
    Olson, Eric
    Russell, Gregory
    Lantz, Jeffrey
    Roberts, Nathan
    Dothard, Andy Shipe
    Lycan, Thomas
    Klepin, Heidi D.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [29] Long Term Clinical Outcomes in Stroke Patients Using Clopidogrel and Proton Pump Inhibitors
    Krishnamurthy, Sibi
    Dandapani, Bhuvaneswari K.
    Dandapani, Nikila B.
    Sunter, Benjamin J.
    Gebel, James B., Jr.
    STROKE, 2010, 41 (04) : E291 - E291
  • [30] Proton pump inhibitors reduce survival outcomes in patients treated with capecitabine: meta-analysis
    Mohyeldeen, Dina
    Arafat, Waleed
    ECANCERMEDICALSCIENCE, 2025, 19